These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25579432)

  • 1. To be drug or prodrug: structure-property exploratory approach regarding oral bioavailability.
    Damião MC; Pasqualoto KF; Polli MC; Parise Filho R
    J Pharm Pharm Sci; 2014; 17(4):532-40. PubMed ID: 25579432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do Drug-likeness Rules Apply to Oral Prodrugs?
    Protti ÍF; Rodrigues DR; Fonseca SK; Alves RJ; de Oliveira RB; Maltarollo VG
    ChemMedChem; 2021 May; 16(9):1446-1456. PubMed ID: 33471444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of esters as prodrugs for oral delivery of beta-lactam antibiotics.
    Mizen L; Burton G
    Pharm Biotechnol; 1998; 11():345-65. PubMed ID: 9760687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced oral bioavailability of DDI after administration of 6-Cl-ddP, an adenosine deaminase-activated prodrug, to chronically catheterized rats.
    Anderson BD; Morgan ME; Singhal D
    Pharm Res; 1995 Aug; 12(8):1126-33. PubMed ID: 7494823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic assessment of luminal degradation of orally effective prodrugs for rational drug development.
    Mizuma T
    J Pharm Sci; 2010 Feb; 99(2):1078-86. PubMed ID: 19623605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prodrug approaches to improving the oral absorption of antiviral nucleotide analogues.
    Peterson LW; McKenna CE
    Expert Opin Drug Deliv; 2009 Apr; 6(4):405-20. PubMed ID: 19382883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal absorption and activation of decitabine amino acid ester prodrugs mediated by peptide transporter PEPT1 and enterocyte enzymes.
    Tao W; Zhao D; Sun M; Wang Z; Lin B; Bao Y; Li Y; He Z; Sun Y; Sun J
    Int J Pharm; 2018 Apr; 541(1-2):64-71. PubMed ID: 29471144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the oral bioavailability of tapentadol via a carbamate prodrug approach: synthesis, bioactivation, and pharmacokinetics.
    Li Y; Wang Y; Zhang R; Liu C; Wei Y; Sun J; He Z; Xu Y; Zhang T
    Drug Deliv Transl Res; 2018 Oct; 8(5):1335-1344. PubMed ID: 29777509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing Oral Bioavailability of Cyclic RGD Hexa-peptides by the Lipophilic Prodrug Charge Masking Approach: Redirection of Peptide Intestinal Permeability from a Paracellular to Transcellular Pathway.
    Schumacher-Klinger A; Fanous J; Merzbach S; Weinmüller M; Reichart F; Räder AFB; Gitlin-Domagalska A; Gilon C; Kessler H; Hoffman A
    Mol Pharm; 2018 Aug; 15(8):3468-3477. PubMed ID: 29976060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage.
    Sohma Y; Hayashi Y; Ito T; Matsumoto H; Kimura T; Kiso Y
    J Med Chem; 2003 Sep; 46(19):4124-35. PubMed ID: 12954064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prodrug design to improve pharmacokinetic and drug delivery properties: challenges to the discovery scientists.
    Jana S; Mandlekar S; Marathe P
    Curr Med Chem; 2010; 17(32):3874-908. PubMed ID: 20858214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a targeted prodrug strategy of enhance oral absorption of poorly water-soluble compounds.
    Chan OH; Schmid HL; Stilgenbauer LA; Howson W; Horwell DC; Stewart BH
    Pharm Res; 1998 Jul; 15(7):1012-8. PubMed ID: 9688053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5'-O-D-valyl ara A, a potential prodrug for improving oral bioavailability of the antiviral agent vidarabine.
    Shen W; Kim JS; Mitchell S; Kish P; Kijek P; Hilfinger J
    Nucleosides Nucleotides Nucleic Acids; 2009; 28(1):43-55. PubMed ID: 19116869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syntheses and pharmacokinetic studies of prodrug esters for the development of oral carbapenem, L-084.
    Isoda T; Ushirogochi H; Satoh K; Takasaki T; Yamamura I; Sato C; Mihira A; Abe T; Tamai S; Yamamoto S; Kumagai T; Nagao Y
    J Antibiot (Tokyo); 2006 Apr; 59(4):241-7. PubMed ID: 16830892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prodrugs: a challenge for the drug development.
    Zawilska JB; Wojcieszak J; Olejniczak AB
    Pharmacol Rep; 2013; 65(1):1-14. PubMed ID: 23563019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do prodrugs deliver?
    Smith DA
    Curr Opin Drug Discov Devel; 2007 Sep; 10(5):550-9. PubMed ID: 17786853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is prodrug design an approach to increase water solubility?
    Sanches BMA; Ferreira EI
    Int J Pharm; 2019 Sep; 568():118498. PubMed ID: 31301465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prodrugs of herpes simplex thymidine kinase inhibitors.
    Yanachkova M; Xu WC; Dvoskin S; Dix EJ; Yanachkov IB; Focher F; Savi L; Sanchez MD; Foster TP; Wright GE
    Antivir Chem Chemother; 2015 Apr; 24(2):47-55. PubMed ID: 26463822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoval-LdC: efficient prodrug of 2'-deoxy-beta-L-cytidine (L-dC), a potent and selective anti-HBV agent.
    Benzaria S; Pierra C; Bardiot D; Cretton-Scott E; Bridges EG; Zhou XJ; Standring D; Gosselin G
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1003-6. PubMed ID: 14565331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prodrugs: design and clinical applications.
    Rautio J; Kumpulainen H; Heimbach T; Oliyai R; Oh D; Järvinen T; Savolainen J
    Nat Rev Drug Discov; 2008 Mar; 7(3):255-70. PubMed ID: 18219308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.